Finally, designing advanced nanocarriers with improved stability, controlled release, and enhanced tumor penetration will further accelerate the clinical translation of GSH-responsive nanomedicine
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits
Importantly, people who already have liver disease are at a higher risk of liver damage from acetaminophen because they likely arent producing enough glutathione
Indeed, numerous studies have reported the association between disrupted ROS homeostasis and disease progression, including cardiovascular diseases [23], neurodegenerative diseases [24], metabolic diseases [25], reproductive system diseases [26], digestive diseases [27], respiratory system diseases [28], cancers [29], inflammation [30] and infectious diseases [31]